Project Grant R24AI194681
Award Date 9/3/25
Completion Date 8/31/30
Dollars Obligated $1.5M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60611, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant of $721,721 to the University of California, Los Angeles (UCLA) to establish the UCLA RAPID, RIGOROUS, RELEVANT IMPLEMENTATION SCIENCE HUB. This five-year grant, running from August 1, 2025 to July 31, 2030, will leverage implementation science to enhance the translation of HIV research into routine clinical practice and improve population health outcomes. Key objectives include providing technical...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a 5-year, $1,546,730 Project Grant under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) to support the continuation and expansion of the Johns Hopkins HIV Implementation Science Hub (Hopkins Hub). The key objectives of this award are to: 1) enhance the technical rigor of implementation science research and build capacity among investigators focused on ending...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) provides $156,160 to Northwestern University to study the structural basis of HIV accessory proteins VPR and VIF. The goal is to contribute to understanding and potentially combating the HIV/AIDS pandemic through structural biology research. The award period runs from September 1, 2025 to August 31, 2027. The...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,379,954 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Scripps Research Institute. The grant, awarded on August 21, 2025, supports research to engineer durable immunity by optimizing HIV vaccine parameters to drive long-lived plasma cell development. The project aims to systematically study the effects of immunogen affinity, valency, adjuvants, vaccine platforms, and...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $240,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Northwestern University to conduct research on characterizing the HIV-1 viral reservoirs that persist even under antiretroviral therapy (ART). The 2-year project aims to identify the cellular sources and genetic diversity of the HIV-1 reservoirs, as well as study the sources and characteristics of the residual viremia...
- The University of Chicago was awarded a $295,276 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), to computationally investigate key morphological transitions in the HIV-1 life cycle. The research aims to develop a mechanistic understanding of viral assembly, maturation, and uncoating processes, which could aid in the design of new antiretroviral therapies targeting...
- This $859,083 Project Grant, awarded on August 21, 2025 by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research), supports the Southeastern HIV Implementation Science Hub led by Vanderbilt University Medical Center (VUMC). The Hub aims to enhance the sustained implementation of evidence-based HIV diagnosis, treatment, and prevention services among academic, community, and clinical partners in the southeastern U.S. The project will...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,568,644 Cooperative Agreement under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Wistar Institute of Anatomy and Biology, a non-profit biomedical research institute. The award aims to develop an individualized HIV cure strategy that combines enhanced neutralizing antibody responses, antiviral adaptive NK cells, and engineered cell-mediated effector strategies. The goal is to characterize...
- The University of Washington (UW) was awarded a $1,246,486 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) on May 13, 2025. The purpose of this grant is to establish the Research Alliance in Implementation Science to End HIV (RAISE) Regional Consultative Hub, which will support Ending the HIV Epidemic (EHE) implementation science efforts in priority jurisdictions. Through...
- This $658,019 Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The purpose of the award is to establish a Rigorous, Rapid, and Relevant Evidence Adaptation and Implementation (R3EDI) Consultation Hub to support the Ending the HIV Epidemic (EHE) initiative. The R3EDI Hub will provide technical assistance, training resources, and consultation support to EHE...